Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|March 30, 2019
[Digital Cardiology]Benjamin Meder, Peter Radke
Advances in Respiratory Medicine|December 22, 2022
Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery HemodynamicsAbdelrahman Elhakim, Martin Knauth, Mohamed Elhakim, et al.
The American Journal of Cardiology|March 17, 2004
Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elutionRainer Hoffmann, Roswitha Langenberg, Peter Radke, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2006
Three-year follow-up after intracoronary beta-radiation therapy for in-stent restenosisEkaterina Iofina, Peter Radke, Daniela Schubert, et al.
The American Journal of Cardiology|January 8, 2008
Effect of statin therapy before Q-wave myocardial infarction on myocardial perfusionRainer Hoffmann, Philipp Haager, Hasna Suliman, et al.
The American Journal of Cardiology|October 30, 2003
Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular functionRainer Hoffmann, Philipp Haager, Jan Arning, et al.
The American Journal of Cardiology|July 13, 2004
Evaluation of a high-dose dexamethasone-eluting stentRainer Hoffmann, Roswitha Langenberg, Peter Radke, et al.
Open Heart|June 22, 2026
Early versus delayed EKOS thrombolysis in intermediate-high risk pulmonary embolism: a retrospective multicentre analysisJulia Schulten-Baumer, Aldelrahman Elhakim, Peter Radke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 15, 2025
Safety and efficacy of thrombolysis with the EkoSonic Endovascular System for intermediate-high risk pulmonary embolism during on- and off-hours: a multicenter studyJulia Schulten-Baumer, Abdelrahman Elhakim, Peter Radke, et al.
European Heart Journal|August 10, 2014
Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trialWilliam Wijns, Ph Gabriel Steg, Laura Mauri, et al.
Pageof 2